GSK Capital B.V., founded in the Netherlands, serves as a financial services entity focusing on innovative investment solutions. The company specializes in the issuance and management of various debt instruments aimed at optimizing funding strategies for its parent organization, GSK plc, a global healthcare leader.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| GSK 2.88% 2031-11-19 EURGSK Capital B.V. | Netherlands | 2031-11-19 | 2.875 | 3.01 |
| GSK 3.00% 2027-11-28 EURGSK Capital B.V. | Netherlands | 2027-11-28 | 3.000 | 2.40 |
| GSK 3.13% 2032-11-28 EURGSK Capital B.V. | Netherlands | 2032-11-28 | 3.125 | 3.11 |
| GSK 3.25% 2036-11-19 EURGSK Capital B.V. | Netherlands | 2036-11-19 | 3.250 | 3.54 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
GSK Capital B.V. began issuing bonds in 2000, establishing a consistent presence in the capital markets. Noteworthy issuances include their 2021 green bond, which raised €500 million to finance sustainable projects, and their recent 2023 bond offering with a yield of 3.25%, competitive within the healthcare sector. Notably, GSK Capital has incorporated sustainability features in its bond structures, aligning with GSK plc's commitment to environmental responsibility and securing investor interest amidst growing market trends toward responsible investing.